The expert working group reviewed the literature on CLDN18 IHC in G/GEJ adenocarcinoma and developed consensus recommendations on the testing algorithm, as well as pre-analytical, analytical, and post-analytical considerations. This evidence concerns the gene CLDN18 and adenocarcinoma.